CSPC Zhongqi Pharmaceutical Technology Co., Ltd.
Clinical trials sponsored by CSPC Zhongqi Pharmaceutical Technology Co., Ltd., explained in plain language.
A Chinese pharmaceutical company, subsidiary of CSPC Pharmaceutical Group.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a vitamin B12 shot help kids with MMA? new trial underway Results expected Oct 2026 (estimated)
- Kidney function may change how this drug works Results expected Oct 2026 (estimated)
- New obesity drug SYH2082 enters first human safety trial Results expected Oct 2026 (estimated)
- Liver function may change how ammoxetine works Results expected Oct 2026 (estimated)
- New drug SYH2085 tested in healthy people for first time Results expected Nov 2026 (estimated)
-
New Long-Acting shot takes aim at Acromegaly's hormone overload
Disease control CompletedAcromegaly is a rare condition where the pituitary gland makes too much growth hormone, causing bones and tissues to enlarge. Researchers are testing a long-acting octreotide injection called SYHX2008 in 78 adults with active acromegaly. Participants receive either the new inject…
Phase 2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Breakfast or not? study tests Food's impact on new pill
Knowledge-focused CompletedThis completed Phase 1 trial tested how a high-fat or low-fat meal changes the way the body absorbs ammoxetine, a potential antidepressant. Eighteen healthy adults each took a single 60 mg dose under three different meal conditions. The goal was to see if food affects drug levels…
Phase 1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Healthy volunteers help uncover Food-Drug interactions
Knowledge-focused CompletedThis study looked at how taking ammoxetine tablets with or without food changes the drug levels in the body. Fourteen healthy adults participated in a two-period crossover design. The goal was to understand food's impact on drug absorption to guide future dosing recommendations.
Phase 1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC